Skip to main content
OpenTrials

Clinical trial condition

Metastatic Cancer

Explore clinical trials studying Metastatic Cancer. Study availability and eligibility vary by location and protocol.

431 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Cancer trial results

Active, not recruiting

First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours

NCT05495295

Conditions
Advanced Solid Tumor, Astrocytoma, Glioblastoma, +15 more
Locations
  • Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
  • IRCCS Ospedale San Raffaele Milan, Italy
  • Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia Reggio Emilia, Italy
  • Institut du Cancer de Montpellier Montpellier, France
View Trial Details
Active, not recruiting

A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815

NCT05557045

Conditions
Advanced Cancer, Anaplastic Thyroid Cancer (ATC), Bronchial Neoplasms, +39 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • SCRI HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
View all 15 locations
View Trial Details
Active, not recruiting

Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer

NCT05502315

Conditions
Castration-resistant Prostate Cancer, Metastatic Cancer, Neoplasm Metastasis, +4 more
Locations
  • University of California San Diego La Jolla, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Active, not recruiting

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

NCT05853575

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
Locations
  • Local Institution - 101 Santa Rosa, California, United States
  • Local Institution - 105 Kansas City, Missouri, United States
  • Local Institution - 100 Durham, North Carolina, United States
  • Local Institution - 106 Dallas, Texas, United States
View all 98 locations
View Trial Details

Related conditions